BRIEF-Agile therapeutics resubmits new drug application for transdermal contraceptive patch
* Agile therapeutics resubmits new drug application (NDA) for its transdermal contraceptive patch, Twirla®
May 3 Humana Inc
* Humana inc says early indicators suggest medical cost utilization trends are running well relative to co's pricing expectations
* Humana inc says "initial indications of medicare premium levels are also encouraging" Further company coverage:
* Dimension Therapeutics completes strategic review and updates corporate priorities
June 27 U.S. stock index futures were lower on Tuesday as a selloff in technology shares continued, while investors awaited clues on interest rate hikes from Federal Reserve Chair Janet Yellen's talk in London.